Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antibody Responses in COVID-19: A Review
Mateo Chvatal-Medina, Yorjagis Mendez-Cortina, Pablo Javier Patiño Grajales, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 137

Showing 1-25 of 137 citing articles:

A focused review on technologies, mechanisms, safety, and efficacy of available COVID-19 vaccines
Parisa Ghasemiyeh, Soliman Mohammadi‐Samani, Negar Firouzabadi, et al.
International Immunopharmacology (2021) Vol. 100, pp. 108162-108162
Open Access | Times Cited: 86
Heterologous prime–boost strategies for COVID-19 vaccines
Binaya Sapkota, Bhuvan Saud, Ranish Shrestha, et al.
Journal of Travel Medicine (2021)
Open Access | Times Cited: 81
SARS-CoV-2 mRNA vaccine induces robust specific and cross-reactive IgG and unequal neutralizing antibodies in naive and previously infected people
Tara M. Narowski, Kristin Raphel, Lily E. Adams, et al.
Cell Reports (2022) Vol. 38, Iss. 5, pp. 110336-110336
Open Access | Times Cited: 49
Reduced Titers of Circulating Anti-SARS-CoV-2 Antibodies and Risk of COVID-19 Infection in Healthcare Workers during the Nine Months after Immunization with the BNT162b2 mRNA Vaccine
Luca Coppeta, Cristiana Ferrari, Giuseppina Somma, et al.
Vaccines (2022) Vol. 10, Iss. 2, pp. 141-141
Open Access | Times Cited: 43
Comparison of hydrophobicity scales for predicting biophysical properties of antibodies
Franz Waibl, Monica L. Fernández‐Quintero, Florian S. Wedl, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 36
Humoral and Cellular Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients with Multiple Sclerosis: An Israeli Multi-Center Experience Following 3 Vaccine Doses
Ron Milo, Elsebeth Staun-Ram, Dimitrios Karussis, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 35
Heterogenous CD8+ T Cell Maturation and ‘Polarization’ in Acute and Convalescent COVID-19 Patients
I. V. Kudryavtsev, N. A. Аrsentieva, Zoia R. Korobova, et al.
Viruses (2022) Vol. 14, Iss. 9, pp. 1906-1906
Open Access | Times Cited: 31
Changes in Anti-SARS-CoV-2 IgG Subclasses over Time and in Association with Disease Severity
Zoia R. Korobova, Е. В. Зуева, N. A. Аrsentieva, et al.
Viruses (2022) Vol. 14, Iss. 5, pp. 941-941
Open Access | Times Cited: 27
Impact of prior SARS-CoV-2 infection and COVID-19 vaccination on the subsequent incidence of COVID-19: a multicentre prospective cohort study among UK healthcare workers – the SIREN (Sarscov2 Immunity & REinfection EvaluatioN) study protocol
Sarah K. Wallace, Victoria Hall, André Charlett, et al.
BMJ Open (2022) Vol. 12, Iss. 6, pp. e054336-e054336
Open Access | Times Cited: 27
A comprehensive review on immunogen and immune-response proteins of SARS-CoV-2 and their applications in prevention, diagnosis, and treatment of COVID-19
Daohong Zhang, Deepak Kukkar, Ki‐Hyun Kim, et al.
International Journal of Biological Macromolecules (2024) Vol. 259, pp. 129284-129284
Closed Access | Times Cited: 6
Impact of differences between interim and post-interim analysis populations on outcomes of a group sequential trial: Example of the MOVe-OUT study
Yoseph Caraco, Matthew G. Johnson, Joseph A. Chiarappa, et al.
Clinical Trials (2025)
Closed Access
Immunity after COVID-19 and vaccination: follow-up study over 1 year among medical personnel
Vivian Glück, Sonja Grobecker, Josef Köstler, et al.
Infection (2021) Vol. 50, Iss. 2, pp. 439-446
Open Access | Times Cited: 36
Humoral Response to BNT162b2 Vaccine Against SARS-CoV-2 Variants Decays After Six Months
Tulio J. Lopera, Mateo Chvatal-Medina, Lizdany Flórez‐Álvarez, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 26
SARS-CoV-2 seroprevalence around the world: an updated systematic review and meta-analysis
Mobin Azami, Yousef Moradi, Asra Moradkhani, et al.
European journal of medical research (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 22
Lack of vitamin D predicts impaired long-term immune response to COVID-19 vaccination
Luigi di Filippo, Stefano Frara, Umberto Terenzi, et al.
Endocrine (2023) Vol. 82, Iss. 3, pp. 536-541
Open Access | Times Cited: 14
Immunogenicity and safety of two doses of the CoronaVac SARS-CoV-2 vaccine in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic diseases in Brazil: a subgroup analysis of a phase 4 prospective study
Nádia Emi Aikawa, Léonard de Vinci Kanda Kupa, Sandra Gofinet Pasoto, et al.
The Lancet Rheumatology (2021) Vol. 4, Iss. 2, pp. e113-e124
Open Access | Times Cited: 31
SARS-CoV-2-Specific and Functional Cytotoxic CD8 Cells in Primary Antibody Deficiency: Natural Infection and Response to Vaccine
Sudhir Gupta, Sudhanshu Agrawal, Ashley Sandoval, et al.
Journal of Clinical Immunology (2022) Vol. 42, Iss. 5, pp. 914-922
Open Access | Times Cited: 21
Immunity after COVID-19 Recovery and Vaccination: Similarities and Differences
Dorota Kamińska, Dominika Dęborska−Materkowska, Katarzyna Kościelska−Kasprzak, et al.
Vaccines (2022) Vol. 10, Iss. 7, pp. 1068-1068
Open Access | Times Cited: 21
SARS-CoV-2 reinfection prevents acute respiratory disease in Syrian hamsters but not replication in the upper respiratory tract
Frederick Hansen, Kimberly Meade‐White, Chad S. Clancy, et al.
Cell Reports (2022) Vol. 38, Iss. 11, pp. 110515-110515
Open Access | Times Cited: 20
Memory B Cells and Memory T Cells Induced by SARS-CoV-2 Booster Vaccination or Infection Show Different Dynamics and Responsiveness to the Omicron Variant
Setsuko Mise‐Omata, Mari Ikeda, Masaru Takeshita, et al.
The Journal of Immunology (2022) Vol. 209, Iss. 11, pp. 2104-2113
Open Access | Times Cited: 19
Single-arm, open-labelled, safety and tolerability of intrabronchial and nebulised bacteriophage treatment in children with cystic fibrosis andPseudomonas aeruginosa
Jagdev Singh, Dominic A. Fitzgerald, Adam Jaffé, et al.
BMJ Open Respiratory Research (2023) Vol. 10, Iss. 1, pp. e001360-e001360
Open Access | Times Cited: 10
SARS-CoV-2 Antibody Response Is Associated with Age and Body Mass Index in Convalescent Outpatients
Bo Zhai, Karen Clarke, David L. Bauer, et al.
The Journal of Immunology (2022) Vol. 208, Iss. 7, pp. 1711-1718
Open Access | Times Cited: 16
Increasing the Efficiency of a National Laboratory Response to COVID-19: a Nationwide Multicenter Evaluation of 47 Commercial SARS-CoV-2 Immunoassays by 41 Laboratories
Maaike van den Beld, Jean‐Luc Murk, Jan Kluytmans, et al.
Journal of Clinical Microbiology (2021) Vol. 59, Iss. 9
Open Access | Times Cited: 21
CoronaVac (Sinovac) COVID-19 vaccine-induced molecular changes in healthy human serum by infrared spectroscopy coupled with chemometrics
Ayça Doğan, Rafig Gurbanov, Mete Severcan, et al.
TURKISH JOURNAL OF BIOLOGY (2021) Vol. 45, Iss. SI-1, pp. 549-558
Open Access | Times Cited: 21
High titers of neutralizing SARS-CoV-2 antibodies six months after symptom onset are associated with increased severity in COVID-19 hospitalized patients
Adin Sejdic, Anders Frische, Charlotte Sværke Jørgensen, et al.
Virology Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top